{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:53:37Z","timestamp":1757314417219},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.065","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T02:11:54Z","timestamp":1483755114000},"page":"909-915","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery"],"prefix":"10.1016","volume":"35","author":[{"given":"Anna Ljunghill","family":"Hedberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karlis","family":"Pauksens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessika","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"K\u00e4yhty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sj\u00f6lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.12.065_b0005","first-page":"CD004884","article-title":"Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures","author":"Ratilal","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.12.065_b0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1179\/016164102101199693","article-title":"Skull base trauma: diagnosis and management","volume":"24","author":"Samii","year":"2002","journal-title":"Neurol Res"},{"key":"10.1016\/j.vaccine.2016.12.065_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3171\/jns.2004.101.5.0757","article-title":"Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial","volume":"101","author":"Eftekhar","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.vaccine.2016.12.065_b0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00268-001-0059-7","article-title":"Post-traumatic cerebrospinal fluid leakage","volume":"25","author":"Friedman","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.vaccine.2016.12.065_b0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005373-199402000-00009","article-title":"Management of petrous bone fractures in children: analysis of 127 cases","volume":"36","author":"Glarner","year":"1994","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2016.12.065_b0030","first-page":"391","article-title":"Post-traumatic meningitis in children: eleven years' analysis","volume":"24","author":"Santos","year":"2011","journal-title":"Acta Med Port"},{"key":"10.1016\/j.vaccine.2016.12.065_b0035","unstructured":"Folkh\u00e4lsomyndighetens allm\u00e4nna r\u00e5d om vaccination mot pneumokocker; 2015."},{"key":"10.1016\/j.vaccine.2016.12.065_b0040","unstructured":"Sweden TPHAo. Rekommendationer om pneumokockvaccination till riskgrupper. <http:\/\/www.folkhalsomyndigheten.se2016>."},{"key":"10.1016\/j.vaccine.2016.12.065_b0045","doi-asserted-by":"crossref","unstructured":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and mortality weekly report. 2012;61:816\u20139.","DOI":"10.1111\/ajt.12073"},{"key":"10.1016\/j.vaccine.2016.12.065_b0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-72-6-869-72-6-869","article-title":"Posttraumatic bacterial meningitis","volume":"72","author":"Hand","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2016.12.065_b0055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03280250039019","article-title":"Protective efficacy of pneumococcal polysaccharide vaccines","volume":"238","author":"Smit","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.12.065_b0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.12.065_b0065","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00005373-199312000-00007","article-title":"Lymphocyte subset responses to trauma and sepsis","volume":"35","author":"Cheadle","year":"1993","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2016.12.065_b0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.12.065_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2172-11-4","article-title":"Divergent adaptive and innate immunological responses are observed in humans following blunt trauma","volume":"11","author":"Kasten","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2016.12.065_b0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000329460","article-title":"Changes in adaptive and innate immunity in patients with acute pancreatitis and systemic inflammatory response syndrome","volume":"11","author":"Mylona","year":"2011","journal-title":"Pancreatol: Off J Int Assoc Pancreatol"},{"key":"10.1016\/j.vaccine.2016.12.065_b0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrn1765","article-title":"Central nervous system injury-induced immune deficiency syndrome","volume":"6","author":"Meisel","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.vaccine.2016.12.065_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2014.12.014","article-title":"Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults","author":"Hedberg","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.12.065_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/01616412.1991.11739959","article-title":"Severe head injury: effect upon cellular immune function","volume":"13","author":"Quattrocchi","year":"1991","journal-title":"Neurol Res"},{"key":"10.1016\/j.vaccine.2016.12.065_b0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3171\/jns.2001.94.5.0706","article-title":"Early immunological defects in comatose patients after acute brain injury","volume":"94","author":"Wolach","year":"2001","journal-title":"J Neurosurg"},{"key":"10.1016\/j.vaccine.2016.12.065_b0105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins","volume":"15","author":"Simell","year":"2008","journal-title":"Clin Vaccine Immunol: CVI."},{"key":"10.1016\/j.vaccine.2016.12.065_b0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/hv.7.9.15996","article-title":"Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults","volume":"7","author":"Musher","year":"2011","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2016.12.065_b0115","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.065_b0120","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380 years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis: An Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2016.12.065_b0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.065_b0130","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans","volume":"208","author":"Xiao","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.12.065_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-10-60","article-title":"The effect of age on the response to the pneumococcal polysaccharide vaccine","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.12.065_b0140","article-title":"Vaccination as primary prevention? The effect of anti-pneumococcal vaccination on the outcome of patients suffering traumatic skull base fractures","author":"Cohen-Inbar","year":"2015","journal-title":"J Neurosurg Sci"},{"key":"10.1016\/j.vaccine.2016.12.065_b0145","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis: An Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2016.12.065_b0150","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.065_b0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10156-013-0601-1","article-title":"Pneumococcal vaccine and opsonic pneumococcal antibody","volume":"19","author":"Song","year":"2013","journal-title":"J Infect Chemoth: Off J Jpn Soc Chemoth"},{"key":"10.1016\/j.vaccine.2016.12.065_b0160","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1016\/j.vaccine.2015.08.080","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18\u201349 years of age, naive to 23-valent pneumococcal polysaccharide vaccine","volume":"33","author":"Bryant","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.065_b0165","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.065_b0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species","volume":"32","author":"Pletz","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2016.12.065_b0175","doi-asserted-by":"crossref","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the advisory committee on immunization practices (ACIP)","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.12.065_b0180","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T07:24:11Z","timestamp":1568705051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X16312993"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}